Tegafur CAS: 17902-23-7

CAS NO: 17902-23-7
Tegafur
Chemical Name: Tegafur
Molecular Formula: C8H9FN2O3
Formula Weight: 200.17
CAS No.: 17902-23-7
Description Review
Description

Tegafur is a medication that is commonly used in the treatment of cancer. It is a prodrug (meaning it is converted into an active form in the body) of 5-fluorouracil (5-FU), which is a commonly used chemotherapy drug. Tegafur is a type of chemotherapy drug called an antimetabolite. It is typically used to treat certain types of gastrointestinal and breast cancers.

Chemical name: 1-{2-Tetrahydrofuryl}-5-fluorouracil Molecular formula: C9H11FN2O3 Formula weight: 216.19 g/mol CAS No: 17902-23-7

Top ten keywords from Google and Synonyms:

  1. Chemotherapy drug
  2. Antimetabolite
  3. Cancer treatment
  4. Tegafur/ Gimeracil/ Oteracil Potassium Capsules
  5. Prodrug
  6. breast cancer
  7. Gastrointestinal cancer
  8. Combination therapy
  9. Chemotherapy regimen
  10. Medical prescription

Synonyms:

  1. FT-0084335
  2. 1-(2-tetrahydrofuryl)-5-fluoro-1,2-dihydropyrimidine-2,4-dione
  3. Tegafur [Japanese]
  4. 1-(tetrahydro-2-furyl)-5-fluorouracil
  5. Ro-2-9757

Health Benefits of Tegafur: Tegafur is prescribed for treating several types of cancer. The drug is most commonly used to treat gastric cancer, breast cancer, and associated metastases in other organs. The purpose of the drug is to slow or stop the growth of cancer cells so that they can be better managed by other forms of therapy. Tegafur helps to accomplish this by interrupting the synthesis of RNA and DNA, which are the building blocks of cancer cells.

Potential Effects of Tegafur: The drug works best when it is taken in combination with other chemotherapy drugs or radiation therapy. It has been shown to enhance the efficacy of other chemotherapy drugs and to produce better overall outcomes in patients. The drug is most effective when it is taken under a physician's supervision as part of a chemotherapy regimen. Tegafur can also be used to relieve some of the symptoms caused by cancer, such as pain and inflammation.

Product Mechanism: Tegafur is a prodrug of 5-FU, meaning that it is converted into 5-FU in the body. 5-FU is an antimetabolite, which means that it interferes with the normal metabolism of cancer cells, leading to their death. 5-FU interferes with the synthesis of RNA and DNA, which are the genetic building blocks of cancer cells. This leads to a disruption in the growth and replication of cancer cells and eventually causes their death.

Safety: Like all chemotherapy drugs, Tegafur can cause side effects. These can include nausea, vomiting, diarrhea, mouth sores, and hair loss. In rare cases, the drug can cause more serious side effects like liver damage or low blood cell counts, which can increase the risk of infection or bleeding. Patients should be monitored closely while taking Tegafur to ensure that they are receiving the appropriate dose and that they are not experiencing any serious side effects.

Dosing Information: Tegafur is available in capsule form and is typically taken once daily with food. The dose of the drug varies based on the type of cancer being treated and the patient's individual needs. Patients should follow their physician's instructions carefully when taking this drug and should not take more or less than prescribed.

Conclusion: Tegafur is an effective chemotherapy drug that is commonly used to treat a variety of cancers. The drug works by interrupting the normal metabolism of cancer cells, leading to their death. When used properly, the drug can produce positive outcomes for patients and help to relieve some of the symptoms associated with cancer. However, like all chemotherapy drugs, Tegafur can cause side effects and should be used under close medical supervision.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code